BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30214238)

  • 1. Prognostic role of long non-coding RNA HNF1A-AS1 in Chinese cancer patients: a meta-analysis.
    Zhuang C; Zheng L; Wang P
    Onco Targets Ther; 2018; 11():5325-5332. PubMed ID: 30214238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and clinical significance of long non-coding RNA HNF1A-AS1 in solid cancers: A systematic review and meta-analysis.
    Zhou X; Fan YH; Wang Y; Liu Y
    Medicine (Baltimore); 2019 Dec; 98(49):e18264. PubMed ID: 31804362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
    Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
    Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA HOXD-AS1 in various cancers: a meta-analysis and TCGA data review.
    Zhang F; Chen X; Xi K; Qiu Z; Wang Y; Gui Y; Hou Y; Chen K; Zhang X
    Onco Targets Ther; 2018; 11():7827-7840. PubMed ID: 30464530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical prognostic value of lncRNA FAM83H-AS1 in cancer patients: a meta-analysis.
    Yang Q; Wang J; Zhong P; Mou T; Hua H; Liu P; Xie F
    Cancer Cell Int; 2020; 20():72. PubMed ID: 32165862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory mechanisms and potential medical applications of HNF1A-AS1 in cancers.
    Zhang Y; Shi J; Luo J; Liu C; Zhu L
    Am J Transl Res; 2022; 14(6):4154-4168. PubMed ID: 35836869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets.
    Shu Q; Liu X; Yang J; Mou T; Xie F
    Medicine (Baltimore); 2022 Oct; 101(42):e31439. PubMed ID: 36281152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA HNF1A-AS1 promotes proliferation and suppresses apoptosis of bladder cancer cells through upregulating Bcl-2.
    Zhan Y; Li Y; Guan B; Wang Z; Peng D; Chen Z; He A; He S; Gong Y; Li X; Zhou L
    Oncotarget; 2017 Sep; 8(44):76656-76665. PubMed ID: 29100339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the prognostic value of long non-coding RNA AFAP1-AS1 for cancer patients in China.
    Liu RH; Wang MY; Chen LY; Yin ZJ; Ji QK; Wang YY; Jin BZ
    Oncotarget; 2018 Jan; 9(8):8100-8110. PubMed ID: 29487718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA.
    Fang C; Qiu S; Sun F; Li W; Wang Z; Yue B; Wu X; Yan D
    Cancer Lett; 2017 Dec; 410():50-62. PubMed ID: 28943452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of lncRNA HNF1A-AS1 promotes cell proliferation and metastasis in osteosarcoma through activation of the Wnt/β-catenin signaling pathway.
    Zhao H; Hou W; Tao J; Zhao Y; Wan G; Ma C; Xu H
    Am J Transl Res; 2016; 8(8):3503-12. PubMed ID: 27648140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.
    Wang J; Zhong P; Hua H
    Technol Cancer Res Treat; 2021; 20():15330338211004915. PubMed ID: 33906548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of long non-coding RNA HNF1A-AS1 is associated with poor prognosis in urothelial carcinoma of the bladder.
    Wang YH; Liu YH; Ji YJ; Wei Q; Gao TB
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2261-2265. PubMed ID: 29762827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer.
    Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q
    World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
    Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
    Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of high LncRNA AFAP1-AS1 expression in various cancers: A systematic review and meta-analysis containing 21 studies.
    Zhou Y; Chen S; Cheng S; Wei Q; Fathy AH; Shan T
    Clin Chim Acta; 2018 Jun; 481():147-153. PubMed ID: 29544748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA HNF1A-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer.
    Zhang G; An X; Zhao H; Zhang Q; Zhao H
    Biomed Pharmacother; 2018 Feb; 98():594-599. PubMed ID: 29289833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA AFAP1-AS1, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis.
    Liu FT; Xue QZ; Zhu PQ; Luo HL; Zhang Y; Hao T
    Onco Targets Ther; 2016; 9():4247-54. PubMed ID: 27471399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.